Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.
Open | $73.480 |
Close | $70.350 |
Volume / Avg. | 346.463K / 488.552K |
Day Range | 70.125 - 74.790 |
52 Wk Range | 35.710 - 89.390 |
Market Cap | $4.541B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 31.91% |
Days to Cover | 18.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nuvalent (NASDAQ: NUVL) through any online brokerage.
Other companies in Nuvalent’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Alkermes (NASDAQ:ALKS).
The latest price target for Nuvalent (NASDAQ: NUVL) was reported by Jefferies on Wednesday, April 17, 2024. The analyst firm set a price target for 97.00 expecting NUVL to rise to within 12 months (a possible 37.88% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Nuvalent (NASDAQ: NUVL) is $70.35 last updated May 3, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Nuvalent.
Nuvalent’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for Nuvalent.
Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.